Posts tagged with "medicene"

James Templeton, I Used to Have Cancer

James Templeton has lived the past 33+ years cancer-free following a stage 4 Melanoma diagnosis. In his new book, I Used to Have Cancer, James chronicles how he created a miracle mindset and a change in lifestyle and diet to overcome his devastating diagnosis – and how he’s now working to inspire others to have hope, even in the face of a terrible disease.

James shares with his readers his own powerful daily routine, including the positive habits, regimens, and recipes he uses to remain healthy day-after-day. He is the also the founder of the Templeton Wellness Foundation, where he regularly chats with and interviews cancer patients, sharing their stories and inspiring others to adapt a lifestyle and mindset that can inspire hope and make all the difference.

Here he offers following healthy lifestyle tips and recipes:

  • Take Your Body To The Cleaners
    It’s so important to sweat every day – whether that’s hopping into a sauna or through physical activity. By sweating, the body can rid itself of toxic wastes and make it easier for the immune system to work its magic.
    Daily detox drinks, like superfood smoothies with powdered greens including chlorella and dandelion team, and seasonal herbal GI cleanses that clear out mold and bacteria are also very important when cleansing the body of unwanted toxins.
  • The East-Meets-West Diet
    Food that’s rich in probiotics, like miso, tempeh and sauerkraut, combined with plenty of leafy, plant-based veggies, like brussel sprouts, are crucial for flooding the system with immune-boosting phytonutrients.
    Phytonutrients may help prevent disease and can keep your body working properly.
  • Super Supplements
    Certain vitamins, amino acids and plant extracts can help the body build up natural defenses and are easy to include in a daily regimen.
    While everyone knows about the power of Vitamin C when fighting a cold, some other important immune-building supplements include proline, lysine, and green tea extract.
  • Make Time For Yourself!
    There is no hidden secret to James’ success – He assures everyone that it’s simply so important to practice the everyday commitment to basic common-sense health rules.
    The body needs a full 8-hours of sleep, lots of purifying water, a diet rich in probiotics and phytonutrients, relaxation, and to practice gratitude and forgiveness every day.

About James Templeton

By all standards of success, James Templeton seemed to have it all. He was a highly successful businessman, had a beautiful wife and daughter, and, only in his early thirties, had his whole life in front of him. To avoid the same fate as his father and grandfather, who both died of heart attacks at a young age, James became an avid runner―a passion that he believed helped him stay fit and healthy. Imagine his shock when, during a routine physical, his doctor noticed a mole on his body that turned out to be a melanoma―a dangerous form of skin cancer. The mole was removed immediately and James, who was diligent in his follow-up exams, appeared to be cancer-free―but only for a short while. When the cancer reappeared and had spread, on the advice of his doctor, James followed the conventional medical protocol, which included surgery and chemotherapy. He was also involved in a clinical trial. When he learned that the treatments weren’t working, James was obviously devastated. He had reached a new low point in his life, and as he lay in the hospital bed, he prayed fervently for help. As if by some miracle, help came to James in the form of three different visitors who would change the course of his life―and help direct him on a path back to health.

About I Used to Have Cancer

I Used to Have Cancer is James Templeton’s memoir―an inspiring look back at his unique journey in overcoming stage 4 melanoma. James takes you with him on a trip crisscrossing America, during which he shares the various natural approaches he followed to battle his cancer―from diet and supplements to meditation and lifestyle adjustments. As his journey continued, you will see first-hand how James’ definition of success changed from making money to seeing the next sunrise. And how he continues finding success by reaching out to others to share the lessons he has learned.
While this book largely focuses on the various methods James used to overcome his own cancer, it is also an inspiring story of not giving up when all other avenues of conventional medicine fail. It is about taking control of your life and finding a way back from the brink of death. It is about being able to tell your friends, “I used to have cancer.”

Parkinsons and Medical Marijuana

Parkinson’s Foundation Hosts Its First-Ever Medical Marijuana and Parkinson’s Disease Conference

The Parkinson’s Foundation will host its first-ever conference focused on medical marijuana and Parkinson’s disease (PD) in Denver, CO, March 6-7, 2019.

The Parkinson’s Foundation is bringing together experts from across the globe to discuss the implications and recommendations of medical marijuana use for people with Parkinson’s,” said James Beck, PhD, chief scientific officer of the Parkinson’s Foundation. “Now that medical marijuana is legal in 31 states and in many other countries, people are equating access to efficacy. It is imperative that we address the clinical implications of medical marijuana use among people with PD.”

The goal of the conference is to bring together a diverse group of experts from academia, clinics, industry, government and the Parkinson’s community to establish a consensus on medical marijuana use in PD. The conference will address the potential benefits and risks of medical marijuana for people with PD, potential delivery methods, safety considerations, approval as a therapeutic for PD patients, and areas for more rigorous clinical research.

“Having worked as a clinician for the past decade in Colorado, a state at the forefront of medical marijuana use, it is clear that people with PD and their families are intensely interested in the potential of marijuana and cannabinoids in helping manage symptoms and other aspects of their disease,” said Benzi Kluger, MD, MS, associate professor of University of Colorado Hospital and co-chair of the conference. “To date, there is more hype than actual data to provide meaningful clinical information to patients with PD. There is a critical need to analyze existing data on medical marijuana and to set priorities for future research.”

Recent results from a survey conducted by the Parkinson’s Foundation and Northwestern University, a Parkinson’s Foundation Center of Excellence, found that:

  • 80% of patients with PD have used cannabis
  • 23% of doctors received formal education on medical marijuana
  • 95% of neurologists have been asked to prescribe medical marijuana

People with PD and their physicians are looking to answer whether medical marijuana can help manage PD symptoms. Few clinical studies have enrolled people with PD to investigate the effects of medical marijuana on PD symptoms. There is currently no conclusive scientific research supporting the benefits of medical marijuana for PD, however, anecdotal evidence suggests that it may help manage Parkinson’s symptoms such as pain, sleep, appetite, nausea and anxiety.

“In order to move the field forward, we need to determine which cannabinoids are likely to be beneficial or harmful, whether people with PD are at risk from side effects, what we are hoping to treat, and how to conduct informative clinical trials,” said A. Jon Stoessl, MD, co-director of the Djavad Mowafaghian Centre for Brain Health at the University of British Columbia, and co-chair of the conference.

The conference is invitation-only. In addition to Parkinson’s specialists, select Parkinson’s advocates living with PD will be invited to provide their perspective. The Foundation will publish suggested practices and areas for further research following the conference.

For more information on medical marijuana and PD, call our Helpline, 1-800-4PD-INFO (473-4636) or visit Parkinson.org/Marijuana.

About the Parkinson’s Foundation
The Parkinson’s Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience and passion of our global Parkinson’s community. For more information, visit www.parkinson.org or call (800) 4PD-INFO (473-4636).

About Parkinson’s Disease
Affecting nearly one million Americans and 10 million worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s and is the 14th-leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for Parkinson’s and 60,000 new cases are diagnosed each year in the United States alone.

Cure for Cancer in Israel

Cancer Researchers in Israel Believe They Will Have A Cure For Cancer In 1 Year

Promising Research with Multi-Agent Toxins

According to the WHO/International Agency for Research on Cancer, 18.1 million cancer cases are diagnosed worldwide each year. Cancer is now the second leading cause of death behind cardiovascular diseases. It is imperative now, more than ever, that we continue to seek new methods to treat this devastating illness.

Recently, Accelerated Evolution Biotechnologies did an interview where stated they believe that they will “offer in a year’s time a complete cure for cancer”. Although it grabs headlines, that is a momentous statement to make. Let’s dig a little deeper into the work that they are currently doing. The premise behind their treatment involves using a multi-agent target toxin treatment to treat cancer. In the past, this type of therapy targeted toxin treatment has involved the introduction of DNA coding for a protein (can be an antibody) into a bacteriophage – which is a virus that infects bacteria. These proteins can then be displayed on the surface of the virus and interact with its surroundings.
The company’s therapy involves a similar phenomenon, but with the use of peptides instead of proteins. Peptides consist of two or more amino acids linked together in a chain. They are smaller than proteins, can serve biological functions, and in many ways are less expensive to reproduce.

Most cancer therapies aim at attacking a target in a cell, on the surface of a particular cell, or in one of its internal pathways.

However, a mutation in one of these targets can make the therapy ineffective. What is being done here, with multi-target toxin therapy, is that several peptides of the cancer cell are being targeted with a peptide toxin to avoid mutations rendering a therapy ineffective. The more targets used, the less likely that a series of mutations will occur simultaneously that will make the therapy ineffective. This will help in not allowing the cancer cell to evade the treatment and continue to replicate, even with some mutations occurring.

This may have the ability to reduce side effects as well, given that the peptides will aim to attack specific targets on the cancer cells that are typically not overexpressed in other healthy cells. In addition, since the peptides are small (the ones they have developed are about 12 amino acids long) and lack a rigid structure, it allows them access to regions of the cell that may be blocked if a larger protein was used.

Overall, they are using a “combination modality” in a very specific manner for an attack of each cancer cell in this therapy. Combinational therapy has been successful before with cancer, HIV, and autoimmune disease among others. The goal of the company is to eventually personalize this to each patient by having a biopsy sent and analyzed for the receptors that it over expresses. The patient would then be administered an individualized concoction developed to treat the disease.

This is exciting and has potential, but more data needs to be presented. Thus far they have concluded mice experimentation and found inhibited human cancer cell growth that did not affect healthy mice cells. They are currently working on beginning a round of clinical trials, which many people will be eager to see the conclusions. Recently, Accelerated Evolution Biotechnologies has been writing patents on a variety of different specific peptides. While their work thus far is enthusing and making headlines, their claim to “offer in a year’s time a complete cure for cancer” is likely premature. Yet, I don’t know a single person, including myself, who wouldn’t hope for that.

Joshua Mansour, M.D. is a board-certified hematologist and oncologist in Stanford, California.  He is currently doing additional work in the field of Hematopoietic Stem Cell Transplantation and Cellular Immunotherapy.